Biejiajian Pill Inhibits Carcinogenesis and Metastasis via the Akt/GSK-3β/Snail Signaling Pathway in Hepatocellular Carcinoma

• Príomhchruthaitheoirí: Jialing Sun (Údar), Weicong Chen (Údar), Bin Wen (Údar), Mingjia Zhang (Údar), Haitao Sun (Údar), Xuemei Yang (Údar), Wenting Zhao (Údar), Lei La (Údar), Haiyan An (Údar), Jie Pang (Údar), Lei Gao (Údar), Songqi He (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Frontiers Media S.A., 2021-03-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Hepatocellular carcinoma (HCC) is among the most usual cancers globally. In China, Biejiajian pill (BJJP), Traditional Chinese Medicine clinical prescription, is broadly utilized for the prevention and therapy of HCC. However, the mechanisms by which BJJP exerts its effects on the prevention of tumo...